Elevated hemoglobin A1c as a possible indicator of diabetes mellitus and diabetic ketoacidosis in schizophrenia patients receiving atypical antipsychotics

Journal of Clinical Psychiatry

Volumn 68, Issue 4, 2007, Pages 533-541

  Henderson, David C ^a,c,d   Cagliero, Enrico ^b,c   Copeland, Paul M ^b,c   Louie, Pearl M ^a,c   Borba, Christina P ^a   Fan, Xiaoduo ^a,c   Freudenreich, Oliver ^a,c   Goff, Donald C ^a,c  

^a Schizophrenia Program   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d Freedom Trail Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; ATORVASTATIN; CARBAMAZEPINE; CHLORPROMAZINE; CLOZAPINE; FLUOXETINE; FUROSEMIDE; GABAPENTIN; HALOPERIDOL; HEMOGLOBIN A1C; HYDROCORTISONE; INSULIN; LAMOTRIGINE; LEVOTHYROXINE; LISINOPRIL; LITHIUM; METOPROLOL; NIFEDIPINE; OLANZAPINE; ORAL ANTIDIABETIC AGENT; PROPRANOLOL; QUETIAPINE; RISPERIDONE; SERTRALINE; UNINDEXED DRUG; VALPROATE SEMISODIUM; VALPROIC ACID; WARFARIN; ZIPRASIDONE;

ADULT; AGED; ARTICLE; CARDIOMYOPATHY; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; ELECTRONIC MEDICAL RECORD; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPEROSMOLARITY; HYPERTENSION; HYPOTHYROIDISM; LABORATORY TEST; MALE; MORBIDITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA;

EID: 34247470659     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v68n0407     Document Type: Article

References (37)

1. Mohan D, Gordon H, Hindley N, et al. Schizophrenia and diabetes mellitus. Br J Psychiatry 1999;174:180-181
2. Ai D, Roper TA, Riley JA. Diabetic ketoacidosis and clozapine. Postgrad Med J 1998;74:493-494
3. Colli A, Cocciolo M, Francobandiera F, et al. Diabetic ketoacidosis associated with clozapine treatment. Diabetes Care 1999;22:176-177
4. Popli A, Konicki P, Jurjus G, et al. Clozapine and associated diabetes mellitus. J Clin Psychiatry 1997;58:108-111
5. Peterson G, Byrd S. Diabetic ketoacidosis from clozapine and lithium cotreatment. Am J Psychiatry 1996;153:737-738
6. Koval M, Rames, LJ, Christie, S. Diabetic ketoacidosis associated with clozapine treatment. Am J Psychiatry 1994;151:1520-1521
7. Henderson DC, Cagliero E, Gray C, et al. Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: a five-year naturalistic study. Am J Psychiatry 2000;157:975-981
8. Maule S, Giannella R, Lanzio M, et al. Diabetic ketoacidosis with clozapine treatment. Diabetes Nutr Metab 1999;12:187-188
9. Gatta B, Rigalleau V, Gin H. Diabetic ketoacidosis with olanzapine treatment. Diabetes Care 1999;22:1002-1003
10. Lindenmayer JP, Patel R. Olanzapine-induced ketoacidosis with diabetes mellitus [letter]. Am J Psychiatry 1999;156:1471
11. Von Hayek D, Huttl V, Reiss J, et al. Hyperglycemia and ketoacidosis associated with olanzapine. Nervenarzt 1999;70:836-837
12. Wirshing DA, Spellberg BJ, Erhart SM, et al. Novel antipsychotics and new onset diabetes. Biol Psychiatry 1998;44:778-783
13. Goldstein LE. Sporn J, Brown S, et al. New-onset diabetes mellitus and diabetic ketoacidosis associated with olanzapine treatment. Psychosomatics 1999;40:438-443
14. Muench J, Carey M. Diabetes mellitus associated with atypical antipsychotic medications: new case report and review of the literature. J Am Board Fam Pract 2001;14:278-282
15. Koller E, Schneider B, Bennett K, et al. Clozapine-associated diabetes. Am J Med 2001;111:716-723
16. Koller EA, Doraiswamy PM. Olanzapine-associated diabetes mellitus. Pharmacotherapy 2002;22:841-852
17. Griffiths J, Springuel P. Atypical antipsychotics: impaired glucose metabolism. CMAJ 2001;165:943-945, 947-949
18. Koller EA, Cross JT, Doraiswamy PM, et al. Risperidone-associated diabetes mellitus: a pharmacovigilance study. Pharmacotherapy 2003; 23:735-744
19. Koller EA, Weber J, Doraiswamy PM, et al. A survey of reports of quetiapine-associated hyperglycemia and diabetes mellitus. J Clin Psychiatry 2004;65:857-863
20. Jin H, Meyer JM, Jeste DV. Phenomenology of and risk factors for new-onset diabetes mellitus and diabetic ketoacidosis associated with atypical antipsychotics: an analysis of 45 published cases. Ann Clin Psychiatry 2002;14:59-64
21. Diabetic ketoacidosis. In: Diabetes Surveillance. Atlanta, Ga: Centers for Disease Control; 1997:161
22. Westphal SA. The occurrence of diabetic ketoacidosis in non-insulin-dependent diabetes and newly diagnosed diabetic adults. Am J Med 1996; 101:19-24
23. Balasubramanyam A. Zern JW, Hyman DJ, et al. New profiles of diabetic ketoacidosis: type 1 vs type 2 diabetes and the effect of ethnicity. Arch Intern Med 1999;159:2317-2322
24. Casteels K, Mathieu C. Diabetic ketoacidosis. Rev Endocr Metab Disord 2003;4:159-166
25. Murphy SN, Morgan MM, Barnett GO, et al. Optimizing healthcare research data warehouse design through past COSTAR query analysis. Proc AMIA Symp 1999:892-896
26. Faich GA, Fishbein HA, Ellis SE. The epidemiology of diabetic acidosis: a population-based study. Am J Epidemiol 1983;117:551-558
27. Henderson DC, Cagliero E, Copeland PM, et al. Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis. Arch Gen Psychiatry 2005;62:19-28
28. Ebenbichler CF, Laimer M, Eder U, et al. Olanzapine induces insulin resistance: results from a prospective study. J Clin Psychiatry 2003;64: 1436-1439
29. Banerji MA, Chaiken RL, Huey H, et al. GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4: Flatbush diabetes. Diabetes 1994;43:741-745
30. Druss BG, Rosenheck RA, Desai MM, et al. Quality of preventive medical care for patients with mental disorders. Med Care 2002;40:129-136
31. Skosnik PD, Chatterton RT Jr, Swisher T, et al. Modulation of attentional inhibition by norepinephrine and cortisol after psychological stress. Int J Psychophysiol 2000;36:59-68
32. Jansen AS, Nguyen XV, Karpitskiy V. et al. Central command neurons of the sympathetic nervous system: basis of the fight-or-flight response. Science 1995;270:644-646
33. Shiloah E, Witz S, Abramovitch Y. et al. Effect of acute psychotic stress in nondiabetic subjects on beta-cell function and insulin sensitivity. Diabetes Care 2003;26:1462-1467
34. Laghate VD, Gupta SB. Acute pancreatitis and diabetic ketoacidosis in non-diabetic person while on treatment with sodium valproate, chlorpromazine and haloperidol. J Assoc Physicians India 2004;52:257-258
35. Johnson DD, Palumbo PJ, Chu CP. Diabetic ketoacidosis in a community-based population. Mayo Clin Proc 1980;55:83-88
36. Leslie DL, Rosenheck RA. Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medications. Am J Psychiatry 2004;161: 1709-1711
37. American Diabetes Association. Consensus development conference on antipsychotic drugs and obesity and diabetes. J Clin Psychiatry 2004; 65:267-272